Your browser doesn't support javascript.
loading
Improving patient outcomes by promoting antimicrobial stewardship for patients with positive blood cultures: Investigation of patients with gram negative bacterium.
Tai, Tatsuya; Yamaguchi, Kazunori; Watanabe, Masahiro; Tanaka, Hiroaki; Okazaki, Tomoya; Watanabe, Naoki; Yokota, Kyoko; Kadowaki, Norimitsu; Kosaka, Shinji.
Afiliação
  • Tai T; Department of Pharmacy, Kagawa University Hospital, Miki, Japan.
  • Yamaguchi K; Infection Control Service Office, Kagawa University Hospital, Miki, Japan.
  • Watanabe M; Department of Pharmacy, Kagawa University Hospital, Miki, Japan.
  • Tanaka H; Infection Control Service Office, Kagawa University Hospital, Miki, Japan.
  • Okazaki T; Department of Pharmacology, School of Pharmacy, Shujitsu University, Okayama, Japan.
  • Watanabe N; Department of Pharmacy, Kagawa University Hospital, Miki, Japan.
  • Yokota K; Infection Control Service Office, Kagawa University Hospital, Miki, Japan.
  • Kadowaki N; Department of Emergency Medicine, Kagawa University Hospital, Miki, Japan.
  • Kosaka S; Infection Control Service Office, Kagawa University Hospital, Miki, Japan.
J Clin Pharm Ther ; 47(10): 1600-1607, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35708200
ABSTRACT
WHAT IS KNOWN AND

OBJECTIVE:

In this study, changes in patient outcomes were analysed to evaluate the effects of prospective audit and feedback (PAF), which was promoted under a new system of antimicrobial stewardship (AS), in patients with gram-negative rod (GNR)-positive blood cultures.

METHODS:

This study included patients with positive blood cultures treated at Kagawa University Hospital between 2019 and 2020. The effects of PAF, as promoted in 2020 and performed within a few days of treatment initiation, were examined in terms of patient prognosis and estimated cost of extra hospital stay associated with GNR infection. RESULTS AND

DISCUSSION:

As AS activities under the new system, proposals were made for targeted therapy based on susceptibility results and for the duration of antimicrobial therapy, escalation and dose increases, and imaging evaluation. Between 2019 and 2020, there was no difference in the rate of de-escalation in the form of switching to a narrower-spectrum intravenous antimicrobial, the rate of image inspection, but the rate of switching to oral therapy after receiving culture results increased from 19.7% to 31.3%, the rate of sensitivity-based treatment increased from 76.4% to 92.2%. Regarding patient outcomes, the 90-day mortality rate and the duration of hospital stay were similar between the groups. The rate of recurrent bloodstream infections decreased from 8.7% to 0.9%. WHAT IS NEW AND

CONCLUSION:

Most of the changes in the indicators related to patient outcomes analysed in this study suggest that the increased use of PAF in AS activities improved patient outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gestão de Antimicrobianos / Anti-Infecciosos Limite: Humans Idioma: En Revista: J Clin Pharm Ther Assunto da revista: FARMACIA / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gestão de Antimicrobianos / Anti-Infecciosos Limite: Humans Idioma: En Revista: J Clin Pharm Ther Assunto da revista: FARMACIA / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão